Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol : Jaein R&P

알림

mobile background

Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol

관리자

논문 게시판

조회수 460

Medicine® / September 18, 2020

Phase I study to evaluate the maximum tolerated

dose of the combination of SH003 and

docetaxel in patients with solid cancer: A study protocol

Link;

https://journals.lww.com/md-journal/Fulltext/2020/09180/Phase_I_study_to_evaluate_the_maximum_tolerated.60.aspx

Herbal Prescription SH003 Alleviates Docetaxel-Induced Neuropathic Pain in C57BL/6 Mice SH003 activates autophagic cell death by activating ATF4 and inhibiting G9a under hypoxia in gastric cancer cells